Nemaura Medical Inc reports results for the quarter ended in September - Earnings Summary

Nemaura Medical

15/11/2022 09:57

* Nemaura Medical Inc  NMRD.OQ  reported a quarterly
adjusted loss
of 17 cents​​ per share for the quarter ended in September. The
mean expectation of three analysts for the quarter was for a
loss of 17 cents per share.
    * Revenue was $74.00 thousand​; analysts expected $200.00
thousand. 
    * Nemaura Medical Inc's reported EPS for the quarter was a
loss
of 17 cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Nemaura Medical Inc shares had risen by 7.2% this
quarter and
lost 51.1% so far this year.
    * The company reported a quarterly loss of $4.08 million.
    * Wall Street's median 12-month price target for Nemaura
Medical
Inc is $8.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
15 at 09:57 a.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.17          -0.17          Met
 Jun. 30 2022      -0.17          -0.17          Met
 Mar. 31 2022      -0.14          -0.15          Missed
 Dec. 31 2021      -0.14          -0.15          Missed